{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:23:08Z","timestamp":1794522188516,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203681"],"award-info":[{"award-number":["82203681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Project for Key Medicine Discipline Construction of Guangzhou Municipality, CHN","award":["2021-2023-17"],"award-info":[{"award-number":["2021-2023-17"]}]},{"name":"Science and Technology Projects in Guangzhou","award":["2024A03J0897"],"award-info":[{"award-number":["2024A03J0897"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02295-w","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T20:04:27Z","timestamp":1742328267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Bingfeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"1","key":"2295_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"7579","key":"2295_CR2","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1038\/527S217a","volume":"527","author":"D Holmes","year":"2015","unstructured":"Holmes D. Ovarian cancer: beyond resistance. Nature. 2015;527(7579):S217.","journal-title":"Nature"},{"issue":"suppl8","key":"2295_CR3","doi-asserted-by":"publisher","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","volume":"28","author":"EL Christie","year":"2017","unstructured":"Christie EL, Bowtell DDL. Acquired chemotherapy resistance in ovarian cancer. Ann Oncol. 2017;28(suppl8):viii13\u20135.","journal-title":"Ann Oncol"},{"issue":"12","key":"2295_CR4","doi-asserted-by":"publisher","first-page":"e2028620","DOI":"10.1001\/jamanetworkopen.2020.28620","volume":"3","author":"CA Penn","year":"2020","unstructured":"Penn CA, Wong MS, Walsh CS. Cost-effectiveness of maintenance therapy based on molecular classification following treatment of primary epithelial ovarian Cancer in the united States. JAMA Netw Open. 2020;3(12):e2028620.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2295_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13046-021-01974-y","volume":"40","author":"GH Li","year":"2021","unstructured":"Li GH, Qu Q, Qi TT, Teng XQ, Zhu HH, Wang JJ, et al. Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance. J Exp Clin Cancer Res. 2021;40(1):174.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"2295_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator Establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307\u201319.","journal-title":"Cell"},{"issue":"9","key":"2295_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrg3207","volume":"13","author":"F Spitz","year":"2012","unstructured":"Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet. 2012;13(9):613\u201326.","journal-title":"Nat Rev Genet"},{"issue":"8","key":"2295_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrc.2016.62","volume":"16","author":"I Sur","year":"2016","unstructured":"Sur I, Taipale J. The role of enhancers in cancer. Nat Rev Cancer. 2016;16(8):483\u201393.","journal-title":"Nat Rev Cancer"},{"key":"2295_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.isci.2019.06.025","volume":"17","author":"X Lin","year":"2019","unstructured":"Lin X, Spindler TJ, de Souza Fonseca MA, Corona RI, Seo JH, Dezem FS, et al. Super-Enhancer-Associated LncRNA UCA1 interacts directly with AMOT to activate YAP target genes in epithelial ovarian Cancer. iScience. 2019;17:242\u201355.","journal-title":"iScience"},{"issue":"1","key":"2295_CR10","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1038\/s41467-022-31919-8","volume":"13","author":"MR Kelly","year":"2022","unstructured":"Kelly MR, Wisniewska K, Regner MJ, Lewis MW, Perreault AA, Davis ES, et al. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer. Nat Commun. 2022;13(1):4247.","journal-title":"Nat Commun"},{"issue":"18","key":"2295_CR11","doi-asserted-by":"publisher","first-page":"9537","DOI":"10.1093\/nar\/gky764","volume":"46","author":"J Slyskova","year":"2018","unstructured":"Slyskova J, Sabatella M, Ribeiro-Silva C, Stok C, Theil AF, Vermeulen W, et al. Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage. Nucleic Acids Res. 2018;46(18):9537\u201349.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2295_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2014.01.005","volume":"346","author":"NA Bowden","year":"2014","unstructured":"Bowden NA. Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy? Cancer Lett. 2014;346(2):163\u201371.","journal-title":"Cancer Lett"},{"key":"2295_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2016.10.027","volume":"597","author":"M Yokoi","year":"2017","unstructured":"Yokoi M, Hanaoka F. Two mammalian homologs of yeast Rad23, HR23A and HR23B, as multifunctional proteins. Gene. 2017;597:1\u20139.","journal-title":"Gene"},{"issue":"5","key":"2295_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703\u20137.","journal-title":"Cell"},{"issue":"7779","key":"2295_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"1","key":"2295_CR16","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1038\/s41598-020-69488-9","volume":"10","author":"Y Nanki","year":"2020","unstructured":"Nanki Y, Chiyoda T, Hirasawa A, Ookubo A, Itoh M, Ueno M, et al. Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing. Sci Rep. 2020;10(1):12581.","journal-title":"Sci Rep"},{"issue":"1","key":"2295_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13046-023-02801-2","volume":"42","author":"X Chen","year":"2023","unstructured":"Chen X, Liu X, Li QH, Lu BF, Xie BM, Ji YM, et al. A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 expression and beta-catenin nuclear accumulation. J Exp Clin Cancer Res. 2023;42(1):230.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7812","key":"2295_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-020-2249-1","volume":"582","author":"Z Cai","year":"2020","unstructured":"Cai Z, Cao C, Ji L, Ye R, Wang D, Xia C, et al. RIC-seq for global in situ profiling of RNA-RNA Spatial interactions. Nature. 2020;582(7812):432\u20137.","journal-title":"Nature"},{"issue":"W1","key":"2295_CR19","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"2295_CR20","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","volume":"73","author":"TL Yeung","year":"2013","unstructured":"Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, et al. TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013;73(16):5016\u201328.","journal-title":"Cancer Res"},{"issue":"3","key":"2295_CR21","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","volume":"45","author":"B Gyorffy","year":"2023","unstructured":"Gyorffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023;45(3):1889\u201398.","journal-title":"Geroscience"},{"issue":"7493","key":"2295_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature12787","volume":"507","author":"R Andersson","year":"2014","unstructured":"Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507(7493):455\u201361.","journal-title":"Nature"},{"key":"2295_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P Icard","year":"2018","unstructured":"Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018;38:1\u201311.","journal-title":"Drug Resist Updat"},{"issue":"6","key":"2295_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.neuron.2023.12.015","volume":"112","author":"D Yang","year":"2024","unstructured":"Yang D, Wang Y, Qi T, Zhang X, Shen L, Ma J, et al. Phosphorylation of pyruvate dehydrogenase inversely associates with neuronal activity. Neuron. 2024;112(6):959\u201371. e8.","journal-title":"Neuron"},{"issue":"1\u20132","key":"2295_CR25","doi-asserted-by":"publisher","first-page":"108540","DOI":"10.1016\/j.ymgme.2024.108540","volume":"143","author":"PW Stacpoole","year":"2024","unstructured":"Stacpoole PW, Dirain CO. The pyruvate dehydrogenase complex at the epigenetic crossroads of acetylation and lactylation. Mol Genet Metab. 2024;143(1\u20132):108540.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2295_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41467-019-13830-x","volume":"11","author":"R Araki","year":"2020","unstructured":"Araki R, Hoki Y, Suga T, Obara C, Sunayama M, Imadome K, et al. Genetic aberrations in iPSCs are introduced by a transient G1\/S cell cycle checkpoint deficiency. Nat Commun. 2020;11(1):197.","journal-title":"Nat Commun"},{"issue":"7788","key":"2295_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","volume":"577","author":"A Tasdogan","year":"2020","unstructured":"Tasdogan A, Faubert B, Ramesh V, Ubellacker JM, Shen B, Solmonson A, et al. Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature. 2020;577(7788):115\u201320.","journal-title":"Nature"},{"key":"2295_CR28","doi-asserted-by":"publisher","first-page":"100797","DOI":"10.1016\/j.drup.2021.100797","volume":"59","author":"AC Goncalves","year":"2021","unstructured":"Goncalves AC, Richiardone E, Jorge J, Polonia B, Xavier CPR, Salaroglio IC, et al. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat. 2021;59:100797.","journal-title":"Drug Resist Updat"},{"key":"2295_CR29","doi-asserted-by":"publisher","first-page":"100796","DOI":"10.1016\/j.drup.2021.100796","volume":"59","author":"R Nussinov","year":"2021","unstructured":"Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: an update and perspective. Drug Resist Updat. 2021;59:100796.","journal-title":"Drug Resist Updat"},{"issue":"7","key":"2295_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41573-022-00493-5","volume":"21","author":"TK Kim","year":"2022","unstructured":"Kim TK, Vandsemb EN, Herbst RS, Chen L. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities. Nat Rev Drug Discov. 2022;21(7):529\u201340.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2295_CR31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934\u201347.","journal-title":"Cell"},{"key":"2295_CR32","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.ebiom.2023.104870","volume":"98","author":"SX Liu","year":"2023","unstructured":"Liu SX, Wang C, Lin RB, Ding WY, Roy G, Wang HB, et al. Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma. EBioMedicine. 2023;98:104870.","journal-title":"EBioMedicine"},{"issue":"7920","key":"2295_CR33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41586-022-04906-8","volume":"607","author":"E Bal","year":"2022","unstructured":"Bal E, Kumar R, Hadigol M, Holmes AB, Hilton LK, Loh JW, et al. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature. 2022;607(7920):808\u201315.","journal-title":"Nature"},{"issue":"18","key":"2295_CR34","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1093\/nar\/gkac778","volume":"50","author":"ZZ Zheng","year":"2022","unstructured":"Zheng ZZ, Xia L, Hu GS, Liu JY, Hu YH, Chen YJ, et al. Super-enhancer-controlled positive feedback loop BRD4\/ERalpha-RET-ERalpha promotes ERalpha-positive breast cancer. Nucleic Acids Res. 2022;50(18):10230\u201348.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2295_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/cr.2008.2","volume":"18","author":"SC Shuck","year":"2008","unstructured":"Shuck SC, Short EA, Turchi JJ. Eukaryotic nucleotide excision repair: from Understanding mechanisms to influencing biology. Cell Res. 2008;18(1):64\u201372.","journal-title":"Cell Res"},{"issue":"13","key":"2295_CR36","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/nar\/24.13.2551","volume":"24","author":"PJ van der Spek","year":"1996","unstructured":"van der Spek PJ, Eker A, Rademakers S, Visser C, Sugasawa K, Masutani C, et al. XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes. Nucleic Acids Res. 1996;24(13):2551\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2295_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrm3822","volume":"15","author":"JA Marteijn","year":"2014","unstructured":"Marteijn JA, Lans H, Vermeulen W, Hoeijmakers JH. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol. 2014;15(7):465\u201381.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2295_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/leu.2017.182","volume":"32","author":"R Szalat","year":"2018","unstructured":"Szalat R, Samur MK, Fulciniti M, Lopez M, Nanjappa P, Cleynen A, et al. Nucleotide excision repair is a potential therapeutic target in multiple myeloma. Leukemia. 2018;32(1):111\u20139.","journal-title":"Leukemia"},{"key":"2295_CR39","doi-asserted-by":"publisher","first-page":"1284853","DOI":"10.3389\/fimmu.2023.1284853","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, Liu FY, Shen Y, Tian Y, Han FJ. Research progress on the mechanism of Glycolysis in ovarian cancer. Front Immunol. 2023;14:1284853.","journal-title":"Front Immunol"},{"issue":"1","key":"2295_CR40","doi-asserted-by":"publisher","first-page":"188563","DOI":"10.1016\/j.bbcan.2021.188563","volume":"1876","author":"K Tyagi","year":"2021","unstructured":"Tyagi K, Mandal S, Roy A. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188563.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"2295_CR41","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/nar\/gkad1193","volume":"52","author":"X Gu","year":"2024","unstructured":"Gu X, Zhuang A, Yu J, Yang L, Ge S, Ruan J, et al. Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A. Nucleic Acids Res. 2024;52(5):2273\u201389.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2295_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20(1):114\u201330.","journal-title":"Autophagy"},{"key":"2295_CR43","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.","journal-title":"Drug Resist Updat"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02295-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T20:43:17Z","timestamp":1742330597000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02295-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2295"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02295-w","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the third affiliated Hospital of Guangzhou Medical University [NO: 2024\u2009\u2212\u2009301] and Liaoning Cancer Hospital & Institute [NO: KY20231103] approved the use of human tissue in this study. Informed consent was obtained from all patients. Animal experiments were approved by the Experimental Animal Ethics Committee of Guangzhou Medical University [NO: S2024-004].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final version of the manuscript and approve it for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}